LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company provides LiDCOunity, a hemodynamic monitor to support clinical decision making; LiDCOrapid, a monitor that analyses the blood pressure waveform to provide information in surgical and critically ill patients to help with fluid and drug management; LiDCOview that offers clinical researchers and users with beat-to-beat hemodynamic data; LiDCOplus, a hemodynamic monitor, which provides assessment of the hemodynamic status of critical care and surgery patients; and accessories, including blood pressure modules. It also offers various closed and open pressure monitoring sets for use in the ICU, operating department, and Cath labs; and Stimpod NMS 450X, a quantitative neuromuscular blocking agent monitor. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom. The company trades on AIM exchange marketplace. The company headquarter is located in United Kingdom. The company was established in the 2001. As of writing, the company status seems to be inactive, which indicates it may not be actively trading on the stock exchanges and may be delisted/merged/suspended/renamed.
TickerLID
Long NameLidco Group PLC
Short NameLidco Group
SectorHealthcare
SubsectorMedical Devices
Subsector 2Health Care
CurrencyGBX
ISIN